Company news

Cyclopharm Limited news in 2023

Cyclopharm Limited's news releases, calls and decks from 2023, newest first.

View company

Cyclopharm Signs First USA Contract for Technegas

December 4, 2023

Cyclopharm Receives USFDA Approval for Technegas

October 1, 2023

Investor Presentation Correction

September 26, 2023

Cyclopharm Investor Update

September 25, 2023

Litigation Update and Receipt of Settlement Payment

August 24, 2023

Half Year Accounts

August 22, 2023

USFDA Approval Process Update

August 8, 2023

Cyclopharm 2023 Half Year Accounts Update - Record Revenues

July 16, 2023

Notification of buy-back - CYC

May 16, 2023

Cyclopharm Confirms USFDA Scheduled Inspection Date

May 8, 2023

USFDA Confirms Technegas Six Month Review Period

April 24, 2023

Technegas Enters Final Six Month USFDA Review Cycle

March 30, 2023

Dividend/Distribution - CYC

February 20, 2023

Decks in 2023